Cargando…
Role of oxidative stress and intracellular glutathione in the sensitivity to apoptosis induced by proteasome inhibitor in thyroid cancer cells
BACKGROUND: The proteasome inhibitor bortezomib has shown impressive clinical activity alone and in combination with conventional and other novel agents for the treatment of multiple myeloma (MM) and some solid cancers. Although bortezomib is known to be a selective proteasome inhibitor, the downstr...
Autores principales: | Du, Zhen-Xian, Zhang, Hai-Yan, Meng, Xin, Guan, Yifu, Wang, Hua-Qin |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2666756/ https://www.ncbi.nlm.nih.gov/pubmed/19216805 http://dx.doi.org/10.1186/1471-2407-9-56 |
Ejemplares similares
-
Resveratrol protects leukemic cells against cytotoxicity induced by proteasome inhibitors via induction of FOXO1 and p27(Kip1)
por: Niu, Xiao-Fang, et al.
Publicado: (2011) -
Involvement of Nrf2 in proteasome inhibition-mediated induction of ORP150 in thyroid cancer cells
por: Zong, Zhi-Hong, et al.
Publicado: (2015) -
Second-generation proteasome inhibitor carfilzomib sensitizes neuroblastoma cells to doxorubicin-induced apoptosis
por: Guan, Shan, et al.
Publicado: (2016) -
Alterations of the Intracellular Peptidome in Response to the Proteasome Inhibitor Bortezomib
por: Gelman, Julia S., et al.
Publicado: (2013) -
The Proteasome Inhibitor Bortezomib Sensitizes AML with Myelomonocytic Differentiation to TRAIL Mediated Apoptosis
por: van Dijk, Marianne, et al.
Publicado: (2011)